Table 3. Primary antibodies used in the IHC panel for primary ureteral malignant leiomyosarcoma in a mixed-breed dog.
Antigen | Clone | Dilution | Antigen retrieval | Source | Reactivity |
---|---|---|---|---|---|
Alpha-smooth muscle actin | 1A4 | 1:1000 | High pH link, DAKO | K800221, Agilent DAKO | Positive |
Smooth muscle myosin heavy chain | SMMS-1 | Ready-to-use | High pH link, DAKO | K800221, Agilent DAKO | Positive |
Actin, muscle specific | HHF-35 | Ready-to-use | High pH link, DAKO | K800221, Agilent DAKO | Positive |
Desmin | D33 | Ready-to-use | High pH link, DAKO | K800221, Agilent DAKO | Positive |
Myogenin | F5D | Ready-to-use | High pH Link, DAKO | K800221, Agilent DAKO | Negative |
Pancytokeratin | AE1AE3 | Ready-to-use | High pH link, DAKO | K800221, Agilent DAKO | Negative |
Uroplakin III | AU1 (UPIII) | 1:20 | High pH link, DAKO | Fitzgerald | Negative |
GATA binding protein 3 (GATA3) | L50-823 | 1:50 | High pH link, DAKO | Biocare Medical | Negative |
SOX10 | BC34 | Ready-to-Use | High pH link, DAKO | Cell Marque | Negative |
GFAP | Polyclonal | Ready-to-use | High pH link, DAKO | K800221, Agilent DAKO | Negative |
GFAP, glial fibrillary acidic protein.